SouthState Corp Has $21.84 Million Position in Danaher Co. (NYSE:DHR)

SouthState Corp grew its holdings in Danaher Co. (NYSE:DHR) by 3.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 94,413 shares of the conglomerate’s stock after acquiring an additional 3,008 shares during the quarter. Danaher accounts for 1.9% of SouthState Corp’s portfolio, making the stock its 11th largest holding. SouthState Corp’s holdings in Danaher were worth $21,842,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Wellington Management Group LLP raised its stake in Danaher by 18.6% in the 3rd quarter. Wellington Management Group LLP now owns 24,930,281 shares of the conglomerate’s stock valued at $6,185,203,000 after acquiring an additional 3,905,449 shares during the period. Bank of New York Mellon Corp increased its holdings in Danaher by 6.5% in the third quarter. Bank of New York Mellon Corp now owns 8,183,501 shares of the conglomerate’s stock worth $2,030,327,000 after purchasing an additional 502,868 shares in the last quarter. Northern Trust Corp increased its holdings in Danaher by 1.7% in the third quarter. Northern Trust Corp now owns 8,100,722 shares of the conglomerate’s stock worth $2,009,789,000 after purchasing an additional 134,905 shares in the last quarter. Flossbach Von Storch AG boosted its position in shares of Danaher by 1.8% during the fourth quarter. Flossbach Von Storch AG now owns 4,601,351 shares of the conglomerate’s stock valued at $1,064,477,000 after buying an additional 82,672 shares during the last quarter. Finally, Fisher Asset Management LLC boosted its position in Danaher by 6.2% in the fourth quarter. Fisher Asset Management LLC now owns 4,227,108 shares of the conglomerate’s stock worth $977,900,000 after purchasing an additional 248,140 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

Danaher stock traded down $0.05 during midday trading on Thursday, reaching $246.84. The company’s stock had a trading volume of 2,732,367 shares, compared to its average volume of 2,779,547. Danaher Co. has a fifty-two week low of $182.09 and a fifty-two week high of $259.00. The firm has a market capitalization of $182.83 billion, a PE ratio of 41.85, a P/E/G ratio of 3.80 and a beta of 0.83. The stock’s 50 day simple moving average is $248.71 and its 200 day simple moving average is $231.90. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.51 and a current ratio of 1.85.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, April 23rd. The conglomerate reported $1.92 earnings per share for the quarter, beating the consensus estimate of $1.72 by $0.20. The firm had revenue of $5.80 billion during the quarter, compared to the consensus estimate of $5.62 billion. Danaher had a return on equity of 11.43% and a net margin of 16.78%. The firm’s revenue for the quarter was down 2.6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $2.36 EPS. On average, equities research analysts forecast that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, April 26th. Stockholders of record on Thursday, March 28th were paid a $0.27 dividend. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.44%. This is a boost from Danaher’s previous quarterly dividend of $0.24. The ex-dividend date of this dividend was Wednesday, March 27th. Danaher’s dividend payout ratio is presently 18.31%.

Analyst Ratings Changes

A number of research analysts recently weighed in on DHR shares. StockNews.com lowered Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, January 31st. Royal Bank of Canada upped their target price on Danaher from $254.00 to $282.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. HSBC upgraded Danaher from a “hold” rating to a “buy” rating and upped their target price for the stock from $250.00 to $280.00 in a report on Wednesday, April 17th. Robert W. Baird increased their price objective on Danaher from $259.00 to $271.00 and gave the company an “outperform” rating in a report on Wednesday, April 24th. Finally, TD Cowen increased their price target on Danaher from $280.00 to $290.00 and gave the stock a “buy” rating in a research report on Wednesday, April 24th. Six research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $267.31.

Insider Transactions at Danaher

In other news, SVP Georgeann Couchara sold 2,622 shares of the business’s stock in a transaction on Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total transaction of $636,280.74. Following the completion of the transaction, the senior vice president now directly owns 4,244 shares in the company, valued at approximately $1,029,891.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Danaher news, Director Walter G. Lohr sold 3,289 shares of the company’s stock in a transaction dated Thursday, February 15th. The shares were sold at an average price of $251.15, for a total value of $826,032.35. Following the transaction, the director now directly owns 14,129 shares in the company, valued at approximately $3,548,498.35. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Georgeann Couchara sold 2,622 shares of the company’s stock in a transaction that occurred on Tuesday, February 13th. The shares were sold at an average price of $242.67, for a total transaction of $636,280.74. Following the transaction, the senior vice president now owns 4,244 shares in the company, valued at approximately $1,029,891.48. The disclosure for this sale can be found here. In the last ninety days, insiders sold 106,565 shares of company stock valued at $26,641,364. Corporate insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.